Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism. (HAMMER)

Hamstring muscle injuries are a common pathology in sports mainly present in sprint and acceleration sports, accounting for about 12% of all football injuries. Because of their frequency, risk of reinjury and financial cost, they can be considered as a public health problem. Improving knowledge of the pathophysiology of hamstring muscle injury appears to be a relevant research focus for prevention purposes.

Study Overview

Detailed Description

This study is a cohort of athletes in the context of suspicion of hamstring muscle injuries.

Study Type

Observational

Enrollment (Actual)

88

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France
        • CHU Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Athletics with thigh injury will be included.

Description

Inclusion Criteria:

  • To be recreational sportsmen, competitions, amateurs, high-level or professional
  • Aged 18 to 50 years
  • Perform an Magnetic Resonance Imaging (MRI) or an ultrasound of the thigh in the context of the suspicion of an acute hamstring muscle injury
  • Injury during sport since less 21 days old.

Exclusion Criteria:

  • a history of surgery of the anterior cruciate ligament with removal of the transplant in the posterior compartment of the thigh
  • an antecedent of surgery of the thigh.
  • inability to understand the French language for completing the self-questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
hamstring muscle lesions
Patients with hamstring muscle lesions in sport will be included. As usual practice they will have Magnetic Resonance Imaging (MRI) or ultrasound, and will answer to self-questionnaire
Magnetic Resonance Imaging (MRI) or ultrasound will be performed to determinate location of the lesion
Magnetic Resonance Imaging (MRI) or ultrasound will be performed to determinate location of the lesion
Self-questionnaire will be completed by patient. In this questionnaire patients will describe the circumstances of the injury and their personal characteristics and level of sporting practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
location of the lesion of injury
Time Frame: at inclusion
Correlation between location of the lesion and mechanism of onset of injury. Location of the lesion will be measured by Magnetic Resonance Imaging (MRI) or ultrasound results. For location of the lesion, it is a combination of the injured muscle, damaged tissue and the area in the posterior compartment of the thigh.
at inclusion
mechanism of onset of injury
Time Frame: at inclusion

Correlation between location of the lesion and mechanism of onset of injury. Location of the lesion will be measured by Magnetic Resonance Imaging (MRI) or ultrasound results.

Mechanism of onset of injury will be check by self-questionnaire.

at inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mapping of hamstring lesions
Time Frame: at inclusion

Analyzed of mapping of hamstring lesions with Magnetic Resonance Imaging (MRI) / ultrasound.

Compare the MRI and ultrasound maps and the performance of the two means to determine the location of the lesion.

at inclusion
volumetric analysis of the hamstrings
Time Frame: at inclusion
A standardization of the images to allow a better comparison between individuals
at inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pascal EDOUARD, MD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 14, 2018

Primary Completion (Actual)

January 27, 2023

Study Completion (Actual)

January 27, 2023

Study Registration Dates

First Submitted

December 11, 2017

First Submitted That Met QC Criteria

December 11, 2017

First Posted (Actual)

December 14, 2017

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 9, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1708231
  • ANSM (Other Identifier: 2025-A02921-48)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sport Injury

Clinical Trials on Magnetic Resonance Imaging (MRI)

Subscribe